Moreover, meta-analysis of Affymetrix microarray gene expression data from 5143 BC patients showed that although elevated RSU-1 mRNA expression was not correlated with overall survival, it was correlated with poor prognosis both in terms of distant metastasis-free survival and remission-free survival22. Here, RSU1 is linked to breast cancer.